
Stand No. :
Visiter le site webWe are pleased to announce the opening of a siliconization line at our state-of-the-art Saint-Quentin Lamotte (SQLM) plant, which safeguards the integrity of sensitive, aggressive and viscous drug products.
What is siliconization?
SGD Pharma, Global market leader in molded glass primary packaging solutions for the pharmaceutical industry, announces the opening of a new siliconization operation at its state-of-the-art Saint-Quentin Lamotte (SQLM) plant.
SGD Pharma, global primary glass packaging leader, has announced the appointment of Fabio Invernizzi as its new General Manager of its West BU.
SGD Pharma marked the start of the New Year by celebrating the renovation of its Saint-Quentin-Lamotte (SQLM) furnace No2 with a lighting ceremony performed by our appointed Godmother, Vanessa Rade, in accordance with glassmaking tradition.
SGD Pharma, announces its goal to become the global market leader in primary pharmaceutical glass packaging. CEO Olivier Rousseau explains that SGD Pharma intends to significantly grow in 2024, with a sustained and consistent approach to its commercial, innovation, industrial, sustainability, HR and M&A strategies.